合計 50 件の最近のインサイダー取引記録が記録されています Theseus Pharmaceuticals, Inc. (THRX), 内訳は 39 件の買い および 8 件の売り. インサイダー買い総額は $29.44M インサイダー売り総額は $4.71M.
最近活動のある主要インサイダーには Orbimed Advisors Llc, Hayden Donald J Jr, Gordon Carl L. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — THRX
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2024-02-14 |
Orbimed Advisors Llc |
10 Percent Owner |
TOB（売り） |
650,600 |
$4.05 |
$2.63M |
- |
| 2024-02-14 |
Hayden Donald J Jr |
Director |
株式返還 |
3,250 |
- |
- |
- |
| 2024-02-14 |
Gordon Carl L |
10 Percent Owner |
株式返還 |
3,250 |
- |
- |
- |
| 2024-02-14 |
Stein Steven H |
Director |
株式返還 |
3,250 |
- |
- |
- |
| 2024-02-14 |
Dukes Iain D. |
Director |
株式返還 |
61,549 |
$4.03 |
$248.33K |
- |
| 2024-02-14 |
Yi Kathy |
Director |
株式返還 |
99,634 |
$4.03 |
$401.99K |
- |
| 2024-02-14 |
Dahms Bradford D. |
President and CFO |
株式返還 |
332,114 |
$4.03 |
$1.34M |
- |
| 2023-11-06 |
Shakespeare William |
See Remarks |
オプション行使（売却） |
251,084 |
$0.32 |
$80.35K |
93,260 |
| 2023-07-17 |
Orbimed Advisors Llc |
10 Percent Owner |
情報に基づく買い |
151,450 |
$3.05 |
$461.92K |
650,600 |
| 2023-07-17 |
Gordon Carl L |
10 Percent Owner |
情報に基づく買い |
151,450 |
$3.05 |
$461.92K |
650,600 |
| 2023-07-17 |
Foresite Capital Management V, Llc |
10 Percent Owner |
情報に基づく買い |
176,550 |
$2.97 |
$524.35K |
1,385,825 |
| 2023-06-13 |
Hayden Donald J Jr |
Director |
RSU 付与（制限付株式） |
3,250 |
- |
- |
3,250 |
| 2023-06-13 |
Gordon Carl L |
10 Percent Owner |
RSU 付与（制限付株式） |
3,250 |
- |
- |
3,250 |
| 2023-06-13 |
Stein Steven H |
Director |
RSU 付与（制限付株式） |
3,250 |
- |
- |
3,250 |
| 2023-06-13 |
Dukes Iain D. |
Director |
RSU 付与（制限付株式） |
3,250 |
- |
- |
3,250 |
| 2023-06-13 |
Yi Kathy |
Director |
RSU 付与（制限付株式） |
3,250 |
- |
- |
3,250 |
| 2023-03-01 |
Clackson Timothy P |
President and CEO |
RSU 付与（制限付株式） |
45,625 |
- |
- |
45,625 |
| 2023-03-01 |
Dahms Bradford D. |
Chief Financial Officer |
RSU 付与（制限付株式） |
17,500 |
- |
- |
17,500 |
| 2023-03-01 |
Kerstein David |
Chief Medical Officer |
RSU 付与（制限付株式） |
17,500 |
- |
- |
17,500 |
| 2023-03-01 |
Rivera Victor |
Chief Scientific Officer |
RSU 付与（制限付株式） |
16,250 |
- |
- |
16,250 |
| 2023-03-01 |
Shakespeare William |
See Remarks |
RSU 付与（制限付株式） |
21,250 |
- |
- |
21,250 |
| 2023-02-17 |
Clackson Timothy P |
President and CEO |
RSU 付与（制限付株式） |
273,750 |
$11.42 |
$3.13M |
273,750 |
| 2023-02-17 |
Dahms Bradford D. |
Chief Financial Officer |
RSU 付与（制限付株式） |
105,000 |
$11.42 |
$1.2M |
105,000 |
| 2023-02-17 |
Kerstein David |
Chief Medical Officer |
RSU 付与（制限付株式） |
105,000 |
$11.42 |
$1.2M |
105,000 |
| 2023-02-17 |
Rivera Victor |
Chief Scientific Officer |
RSU 付与（制限付株式） |
97,500 |
$11.42 |
$1.11M |
97,500 |
| 2023-02-17 |
Shakespeare William |
See Remarks |
RSU 付与（制限付株式） |
127,500 |
$11.42 |
$1.46M |
127,500 |
| 2022-12-30 |
Hayden Donald J Jr |
Director |
情報に基づく買い |
9,900 |
$5.00 |
$49.49K |
10,000 |
| 2022-12-29 |
Hayden Donald J Jr |
Director |
情報に基づく買い |
100 |
$5.00 |
$500.00 |
100 |
| 2022-12-29 |
Foresite Capital Management V, Llc |
Director |
情報に基づく買い |
250,000 |
$5.00 |
$1.25M |
1,209,275 |
| 2022-11-30 |
Dahms Bradford D. |
Chief Financial Officer |
情報に基づく買い |
1,502 |
$6.66 |
$10K |
6,142 |
| 2022-11-11 |
Clackson Timothy P |
President and CEO |
情報に基づく買い |
2,500 |
$6.80 |
$17K |
351,030 |
| 2022-11-07 |
Orbimed Advisors Llc |
Director |
情報に基づく買い |
192,000 |
$5.21 |
$1M |
16,734,518 |
| 2022-11-07 |
Gordon Carl L |
Director |
情報に基づく買い |
192,000 |
$5.21 |
$1M |
16,734,518 |
| 2022-10-17 |
Stein Steven H |
Director |
不明 |
- |
- |
- |
- |
| 2022-10-17 |
Stein Steven H |
Director |
RSU 付与（制限付株式） |
60,000 |
- |
- |
60,000 |
| 2022-06-10 |
Gordon Carl L |
10 Percent Owner |
RSU 付与（制限付株式） |
30,000 |
$5.75 |
$172.5K |
30,000 |
| 2022-06-10 |
Dukes Iain D. |
Chairman |
RSU 付与（制限付株式） |
15,000 |
- |
- |
15,000 |
| 2022-06-10 |
Yi Kathy |
Director |
RSU 付与（制限付株式） |
30,000 |
- |
- |
30,000 |
| 2022-06-09 |
Foresite Capital Management V, Llc |
Director |
不明 |
- |
- |
- |
959,275 |
| 2022-05-17 |
Hayden Donald J Jr |
Director |
不明 |
- |
- |
- |
- |
| 2022-05-17 |
Hayden Donald J Jr |
Director |
RSU 付与（制限付株式） |
60,000 |
$8.02 |
$481.2K |
60,000 |
| 2022-02-18 |
Clackson Timothy P |
President and CEO |
RSU 付与（制限付株式） |
450,000 |
$11.21 |
$5.04M |
450,000 |
| 2022-02-18 |
Dahms Bradford D. |
Chief Financial Officer |
RSU 付与（制限付株式） |
150,000 |
$11.21 |
$1.68M |
150,000 |
| 2022-02-18 |
Kerstein David |
Chief Medical Officer |
RSU 付与（制限付株式） |
150,000 |
$11.21 |
$1.68M |
150,000 |
| 2022-02-18 |
Dalgarno David |
Chief Technical Officer |
RSU 付与（制限付株式） |
130,000 |
$11.21 |
$1.46M |
130,000 |
| 2022-02-18 |
Rivera Victor |
Chief Scientific Officer |
RSU 付与（制限付株式） |
130,000 |
$11.21 |
$1.46M |
130,000 |
| 2022-02-18 |
Shakespeare William |
See Remarks |
RSU 付与（制限付株式） |
180,000 |
$11.21 |
$2.02M |
180,000 |
| 2022-01-21 |
Orbimed Advisors Llc |
10 Percent Owner |
情報に基づく買い |
111,896 |
$9.97 |
$1.12M |
16,542,652 |
| 2022-01-21 |
Gordon Carl L |
10 Percent Owner |
情報に基づく買い |
111,896 |
$9.97 |
$1.12M |
16,542,652 |
| 2022-01-20 |
Orbimed Advisors Llc |
10 Percent Owner |
情報に基づく買い |
35,000 |
$9.95 |
$348.25K |
16,430,756 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
